Benzinga | Oct 28, 2020 04:44PM EDT

Alimera Sciences Q3 EPS $(0.12) Beats $(0.44) Estimate, Sales $12.47M Beat $10.89M Estimate

Alimera Sciences (NASDAQ:ALIM) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.44) by 72.73 percent. This is a 200 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $12.47 million which beat the analyst consensus estimate of $10.89 million by 14.54 percent. This is a 2.93 percent decrease over sales of $12.85 million the same period last year.